From the Alliance

Seeing the headlines coming out of last week’s Senate Judiciary Committee hearing on patent eligibility law, you’d think this issue is about drug pricing. But you’d be wrong. The real issue is whether or not America will… Read More »

WASHINGTON D.C. – A broad coalition of groups have issued statements expressing support for the reintroduction the bipartisan, bicameral the Patent Eligibility Restoration Act (PERA) in the Senate and House of Representatives by Senators Chris Coons (D-DE)… Read More »

For Immediate Release July 14, 2026 Innovation Alliance Statement on Senate Judiciary Committee Hearing on Patent Eligibility Restoration Act PERA is Needed to Fix Broken Patent Eligibility Laws Bipartisan Bill Would Restore Certainty and Predictability  and Ensure… Read More »

WASHINGTON D.C. – A broad coalition of groups have issued statements expressing support for the reintroduction the bipartisan, bicameral RESTORE Patent Rights Act in the Senate and House of Representatives by Senators Coons (D-DE) and Cotton (R-AR)… Read More »

For Immediate Release April 30, 2026 Innovation Alliance Applauds Trump Administration for Making Strong Patent Rights a Priority in 2026 USTR Special 301 Report  Report Includes New Section Detailing Foreign Country Efforts to Devalue SEP and Other… Read More »

Congress Should Pass PREVAIL Act to Reform PTAB and Promote U.S. Global Technology Leadership Read the fact sheet here.

On January 28, 2026 the Innovation Alliance submitted a response to the Request for Comments Regarding the 2026 Special 301 Review issued by the Office of the United States Trade Representative Read the comments here.